Heart failure ketosis

Journal of Internal Medicine

Volumn 242, Issue 3, 1997, Pages 231-238

  Lommi, J ^a   Koskinen, P ^a   Naveri H ^a   Harkonen M ^a   Kupari, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acetoacetate; B hydroxybutyrate; Fasting; Ketone bodies

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HEART FAILURE; HUMAN; INSULIN BLOOD LEVEL; KETOACIDOSIS; MALE; PRIORITY JOURNAL;

EID: 0030768255     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00187.x     Document Type: Article

References (31)

1. Packer M. Pathophysiology of chronic heart failure. Lancet 1992; 340: 88-92.
2. Ansari A. Syndromes of cardiac cachexia and the cachectic heart: current perspective. Progr Cardiovasc Dis 1987; 30: 45-60.
3. Morrison WL, Edwards RHT. Cardiac cachexia. Br Med J 1991; 303: 301-2.
4. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964; 271: 403-9.
5. Riley M, Elborn JS, Bell N, Stanford CF, Nicholls DP. Substrate utilization during exercise in chronic cardiac failure. Clin Science 1990; 79: 89-95.
6. Kupari M, Lommi J, Ventilä M, Karjalainen U. Breath acetone in congestive heart failure. Am J Cardiol 1995; 76: 1076-8.
7. Lommi J, Kupari M, Koskinen P, Näveri H, Leinonen H, Pulkki K, Härkönen M. Blood ketone bodies in congestive heart failure. J Am Coll Cardiol 1996; 28: 665-72.
8. Lowry OH, Passoneau JV. A Flexible System of Enzymatic Analysis. New York, USA: Academic Press, 1972; 199-201, 212-3.
9. Williamson DH, Mellanby J, Krebs HA. Enzymic determination of D-β-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 1962; 82: 90-96.
10. Miles JR, Glasscock J, Aikens J, Gerich J, Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 1983; 24: 96-9.
11. Scheinin M, Koulu M, Laurikainen E, Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmac 1987; 24: 645-53.
12. Balasse EO, Féry F. Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 1989; 5: 247-70.
13. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive heart failure. Circulation 1989; 80: 299-305.
14. Johnston DG, Pernet A, McCulloch A, Blesa-Malpica G, Burrin JM, Alberti KGMN. Some hormonal influences on glucose and ketone body metabolism in normal human subjects. In: Metabolic Acidosis (Ciba Foundation Symposium No. 87). London, UK: Pitman Books Ltd, 1982; 168-91.
15. Keller U, Gerber PPG, Stauffacher W. Stimulatory effect of norepinephrine on ketogenesis in normal and insulin deficient humans. Am J Physiol 1984; 247: E732-9.
16. Metcalfe P, Johnston DG, Nosadini R, Ørskov H, Alberti KGMM. Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man. Diabeteologia 1981; 20: 123-8.
17. Møller N, Jørgensen JO, Møller J, Ørskov L, Ovesen P, Schmitz O, et al. Metabolic effects of growth hormone in humans. Metabolism 1995; 44 (Suppl. 4): 33-6.
18. Schade DS, Eaton RP. The regulation of plasma ketone body concentration by counter-regulatory hormones in man: III. Effects of norepinephrine in normal man. Diabetes 1979; 28: 5-10.
19. Schade DS, Eaton RP, Standefer J. Glucocorticoid regulation of plasma ketone body concentration in insulin deficient man. J Clin Endocrinol Metab 1977; 44: 1069-79.
20. Carr JG, Stevenson LW, Waiden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709-13.
21. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994; 121: 860-62.
22. Schwengel RH, Gottlieb SS, Fisher ML. Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive failure. Am J Cardiol 1994; 73: 908-10.
23. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
24. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991, 66: 356-8.
25. Foster DW. From glycogen to ketones - and back. Diabetes 1984; 33: 1188-99.
26. Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 1991; 40: 972-7.
27. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJ. Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J 1994; 15: 1528-32.
28. Williams B. Insulin resistance: shape of things to come. Lancet 1994; 344: 521-4.
29. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988; 37: 287-301.
30. Riley M, Bell N, Elborn JS, Stanford CF, Buchanan KD, Nicholls DP. Metabolic responses to graded exercise in chronic heart failure. Eur Heart J 1993; 14: 1484-8.
31. Bailey JW, Haymond MW, Miles JM. Validation of two-pool model for in vivo ketone body kinetics. Am J Physiol 1990; 258: E850-5.